Geode Capital Management’s Cytek Biosciences CTKB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.4M	Buy	2,833,955 +43,381	+2%	+$205K	﹤0.01%	2257
2025 Q4	$14.1M	Buy	2,790,574 +7,125	+0.3%	+$33.1K	﹤0.01%	2207
2025 Q3	$9.66M	Buy	2,783,449 +53,856	+2%	+$202K	﹤0.01%	2433
2025 Q2	$9.28M	Buy	2,729,593 +42,916	+2%	+$143K	﹤0.01%	2416
2025 Q1	$10.8M	Buy	2,686,677 +47,594	+2%	+$247K	﹤0.01%	2246
2024 Q4	$17.1M	Sell	2,639,083 -28,921	-1%	-$172K	﹤0.01%	2053
2024 Q3	$14.8M	Buy	2,668,004 +89,210	+3%	+$506K	﹤0.01%	2146
2024 Q2	$14.4M	Buy	2,578,794 +70,778	+3%	+$425K	﹤0.01%	2116
2024 Q1	$16.8M	Buy	2,508,016 +51,481	+2%	+$407K	﹤0.01%	2025
2023 Q4	$22.4M	Buy	2,456,535 +102,083	+4%	+$642K	﹤0.01%	1839
2023 Q3	$13M	Buy	2,354,452 +292,150	+14%	+$2.34M	﹤0.01%	2098
2023 Q2	$17.6M	Buy	2,062,302 +192,832	+10%	+$1.73M	﹤0.01%	1939
2023 Q1	$17.2M	Buy	1,869,470 +83,335	+5%	+$896K	﹤0.01%	1906
2022 Q4	$18.2M	Buy	1,786,135 +55,467	+3%	+$745K	﹤0.01%	1828
2022 Q3	$25.5M	Buy	1,730,668 +585,198	+51%	+$7.6M	﹤0.01%	1561
2022 Q2	$12.3M	Buy	1,145,470 +224,330	+24%	+$2.23M	﹤0.01%	2110
2022 Q1	$9.93M	Buy	921,140 +566,000	+159%	+$7.64M	﹤0.01%	2346
2021 Q4	$5.79M	Buy	355,140 +34,032	+11%	+$713K	﹤0.01%	2816
2021 Q3	$6.87M	Buy	+321,108	New	+$7.55M	﹤0.01%	2722